The Rajasthan State Health Assurance Agency has permanently revoked 31 drug licenses due to fraudulent claims and price inflation in the government health scheme. This crackdown aims to reduce financial leakage in public health programs, with authorities now focusing on recovering excess payments and improving future billing transparency.
The Rajasthan government has taken strict regulatory action to curb financial irregularities within the Rajasthan Government Health Scheme. Following an audit powered by artificial intelligence, authorities permanently cancelled the drug licenses of 31 pharmacies across the state. This move follows the discovery of systematic misconduct, including the submission of fake medical claims, the use of forged signatures, and the deliberate inflation of medicine prices.
AI Audit Identifies Billing Discrepancies
The Rajasthan State Health Assurance Agency utilized data analytics to monitor claim patterns, which exposed significant gaps between reported costs and actual market benchmarks. The investigation highlighted that several pharmacies failed to provide the mandatory 40% discount required under the government scheme, in some cases offering as little as 12%. Furthermore, specific high-cost medications were billed at two to five times their standard purchase price, drawing the attention of the state’s Drug Control Department.
Regional Impact and Enforcement
The license cancellations were distributed across several districts to address the widespread nature of the irregularities. Jaipur recorded the highest number of closures with 11 pharmacies losing their licenses, while nine were closed in Bharatpur. Other affected areas include Nagaur, Dholpur, Hanumangarh, Bhilwara, Sikar, Jodhpur, and Alwar. In addition to these permanent cancellations, the agency has temporarily suspended services for 10 other stores and issued show-cause notices to 13 additional outlets pending further review.
Financial Accountability and Next Steps
Beyond the immediate impact on pharmacy operations, the state agency is actively working to recover excess payments made through these fraudulent claims. The RSHAA is currently formulating a more robust action plan to ensure that medicine procurement and beneficiary services remain transparent. For stakeholders and healthcare providers involved in similar government-backed schemes, the key monitorable will be the implementation of stricter compliance protocols and the impact of these tighter auditing standards on future operational margins. The government’s focus on using technology to prevent over-billing serves as a warning for entities participating in public health insurance programs to ensure strict adherence to pricing mandates and record-keeping requirements.